Clinical pearls for the treatment of narcolepsy. [PDF]
Bulloch MN, Geyer JD.
europepmc +1 more source
Wide implications of a trial on pitolisant for cataplexy [PDF]
openaire +3 more sources
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in mice. [PDF]
Ebdah W +6 more
europepmc +1 more source
Editorial: Non-invasive methods in drug metabolism and transport: insights from biological samples to oral administration. [PDF]
Wróblewski K, Zheng Y, Yue X.
europepmc +1 more source
Drug Interactions With Excessive Daytime Sleepiness Treatments. [PDF]
Thomas SV +3 more
europepmc +1 more source
Histamine H3 Receptor Antagonists Influence the Directional Growth of Type II Spiral Ganglion Neurites Within the Developing Cochlea of C57BL/6 Mice. [PDF]
Kong L, Olze H, Szczepek AJ.
europepmc +1 more source
Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors. [PDF]
Łażewska D +15 more
europepmc +1 more source
A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1. [PDF]
Xu Q +5 more
europepmc +1 more source
0614 Safety and Tolerability of Pitolisant in the Treatment of Adults With Narcolepsy: Integrated Data From Clinical Studies [PDF]
Catherine Scart‐Grès +5 more
openalex +1 more source

